[YMAB] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 18.72%
YoY- -37.25%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 10,951 5,383 20,750 0 0 0 0 -
PBT -22,937 33,413 -19,933 -32,832 -40,393 -26,179 -23,136 -0.57%
Tax -216 338 2,086 0 0 0 -79 95.65%
NP -22,937 33,413 -19,933 -32,832 -40,393 -26,179 -23,136 -0.57%
Tax Rate - -1.01% - - - - - -
Total Cost 33,888 -28,030 40,683 32,832 40,393 26,179 23,136 29.00%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -209.45 620.71 -96.06 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.53 0.80 -0.48 -0.82 -1.01 -0.66 -0.61 -8.95%
EPS Diluted -0.53 0.75 -0.45 -0.82 -1.01 -0.66 -0.58 -5.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.